Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

Pharma Talk Radio



Follow This Show

Stay in the know about new episodes and updates.
Guest hosts interview industry insiders on strategies, business models, leadership, technologies & innovations in advancing drug development for the benefit of patients. More specifically: clinical trials, patient-centricity, mobile/digital in R&D, drug delivery, emerging biotechs and Immuno-Oncology. PharmaTalkRadio is a non-profit program to provide easy and free access of helpful information for professionals in life sciences as well as patient advocates. It is organized and supported by the Conference Forum.

On-Demand Episodes

We are delighted to bring the Patients as Partners US event to Europe on February 6-7 in London. We would like to thank our European attendees at the US conference for challenging and encouraging us to bring the conference to... more

The 3rd annual DPharm Europe: Disruptive Innovations to Advance Clinical Trials event is led by Co-Chairs Dr Sue Collier (GSK) and Dr Jeff Kasher (Patients Can't Wait). This radio blogcast gives a five minute overview of the event, which... more

The 3rd annual Immuno-Oncology 360° event takes place February 1-3, 2017 in NYC. Lead advisors, Dr Axel Hoos (GSK) and Dr James Gulley (NCI) co-present a program that provides a 360-degree approach addressing the... more

Members of the DPharm team engage in an informal conversation to highlight what's happening in innovation and the latest thinking to disrupt clinical trials at the 6th annual event. Also discussed is a brief history of how this conference... more

Pfizer's ?Blue Sky? approach to transforming clinical research in Parkinson's disease is an inspiring example of patient-centric innovation. Conference Forum's, Valerie Bowling welcomes co-host, Ed Miseta, Clinical Leader.com in a... more

This discussion provides helpful approaches for Chief Medical Officers (CMOs) and other R&D leadership in biotech on how to communicate effectively in times of good, bad or unexpected news. Also discussed in this program are factors... more

What is the quality, capacity and efficiency of running clinical trials in Puerto Rico? In this discussion we speak with Dr Myrto Lee, Director, PwC's Strategy&, UK and Dr Kosmas Kretsos, Executive Director of the Puerto Rico Consortium... more

Frustrated that a promising therapy for a rare cancer was sitting in a freezer due to the lack of a relatively modest amount of funding, author Alexander Masters helped lead a campaign to crowd-fund a clinical trial: the result, iCancer.org.uk.... more

Generic drugs can be repurposed to create effective treatments in unsolved diseases. However, there is no economic incentive for industry to pay for a clinical validation and regulatory approval process for most generic drug repurposing... more

Pharmatalk's Valerie Bowling welcomes Anton (Tony) Hoos, MD, PhD, Head of Medical, Amgen Europe and Marc Boutin, JD, Chief Executive Officer, National Health Council. We address how industry and patients can work together to... more